Hypothalamic and Pituitary Pharmacology Flashcards

1
Q

what increases GH release from the anterior piruitary

A

GHRH, exercise, hypoglycemia, dopamine, l-DOPA, arginine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the treatment for patients who are growth hormone insensitive (receptor mutation) as in Laron dwarf

A

recombinant IGF-1 (Mecasermin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

______ is a GHRH analog available for use in HIV patients with lipodystrophy secondary to use of highly active retroviral therapy (HAART) - reduces excess abdominal fat

A

Tesamorelin (Egrifta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the MOA of somatostatin

A

Inhibits GH release via GPCR coupled to Gi decreasing cAMP levels and activating K+ channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the MOA of GHRH

A

Rapidly stimulates GH synthesis and secretion via binding to GPCR coupled to Gs -> increasing cAMP and Ca++ levels in somatotrophs - no receptor down-regulation with continuous stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the Uses of Somatostatin Analogs

A

1) treat excess of growth hormon: Acromegaly, gigantism

2) To Control of bleeding from esophageal varices and GI hemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Pegvisomant

A

GH receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the side effects of somatostatins

A

1) transient hyperglycemia
2) Abdominal cramps and loose stools
3) cardiac (bradycardia, conduction disturbances)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prolactin release is under inhibitory control by _____

A

hypothalamic dopamine at D2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The Main stimulus for prolactin release is ______

A

suckling - causes 10-100-fold increase within 30 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are Cabergoline and Bromocriptine

A

Dopamine agonists used on the Tx of hyperprolactinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which dopamine agonist is more effective in reducing prolactin secretion and Better tolerated

A

Cabergoline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is Desmopressin?

A

ADH analog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the Renal actions of ADH

A

Mediated by V2 receptors (GPCRs coupled to Gs)
Increases the rate of insertion of water channels (aquaporins) into luminal membrane -> increased water permeability -> leading to an antidiuretic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the treatment of choice for Central Diabetes Insipidus

A

Desmopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Chlorpropamide

A

1st generation sulfonylurea, that can be used in the treatment of ADH defieciency.
• Potentiates action of small or residual amounts of ADH - mechanism not clear
• Option for patients intolerant (side effects-allergy) to desmopressin

17
Q

what are the causes of drug induced Nephrogenic diabetes insipidis

A
  • Lithium: reduces V2-receptor mediated stimulation of adenylyl cyclase. As many as 1/3 of patients treated with Li+ may develop nephrogenic diabetes insipidus
  • Demeclocyline (tetracycline antibiotic): mechanism not completely understood but possibly acts via block of ADH binding to receptor
18
Q

what is the treatment for Nephrogenic Diabetes Insipidus

A
  • Thiazide diuretics: Paradoxically reduce the polyuria of patients with DI. Mechanism not completely understood but antidiuretic effect parallels ability to cause natriuresis - used in doses that mobilize edema fluid.
  • NSAIDs: Since prostaglandins attenuate ADH-induced antidiuresis, inhibition of PG synthesis by indomethacin may relate to the antidiuretic response seen. Indomethacin has greatest efficacy among NSAIDs.
19
Q

what is the Treatment of hyponatremia seen in SIADH

A

1) Restriction of free water intake is initial conservative approach
2) Demeclocyline inhibits ADH effect on distal tubule and has been preferred drug in patients with inadequate response to conservative measures
3) V2 receptor antagonist - potential therapeutic advance for hyponatremia (also tried in HF).
Tolvaptan (Samsca®) - oral route, expensive
Conivaptan (Vaprisol®) - IV infusion (useful in hospitalized SIADH patients) - if severe symptomatic hyponatremia present, conivaptan can be given with hypertonic saline (3%), permitting a more rapid initial correction

20
Q

too rapid correction of hyponatremia can cause _____

A

cerebellar pontine myelinolysis

21
Q

Von Willebrand’s disease and moderate hemophilia A can be treated by _____

A

IV desmopressin, (elevates von Willebrand factor,

elevates factor VIII)

22
Q

nocturnal enuresis can be treated with ____

A

oral desmopressin